Holen Sie sich die Stockscreener-App
4.78
2.14%
0.10
Nuvation Bio Inc Aktie (NUVB) Neueste Nachrichten
3 Promising Penny Stocks With Market Caps Over $200M - Simply Wall Street
Nuvation Bio Inc. (NUVB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Nuvation Bio Inc. (NUVB) stock price, news, quote and history - Yahoo Finance Singapore
Nuvation Bio Inc. (NUVB) stock price, news, quote and history - Yahoo Finance UK
What Makes Nuvation Bio (NASDAQ:NUVB) Stand Out in Nasdaq Biotech? - Kalkine Media
Elite Penny Stocks To Watch In October 2026 - Simply Wall Street
Citigroup Initiates Nuvation Bio at Buy With $12 Price Target - Moomoo
Nuvation stock, Jazz stock gain new Buys at Citi (NUVB:NYSE) - Seeking Alpha
Citigroup Initiates Nuvation Bio at Buy With $12 Price Target - Yahoo Finance
Nuvation Bio Inc. (NUVB): Investor Outlook With A 115.82% Potential Upside - DirectorsTalk Interviews
Why Is Nuvation Bio Stock Gaining Thursday? - Benzinga
Nuvation Bio stock gains on FDA label update for IBTROZI - Investing.com
Nuvation Bio Inc. (NUVB) latest stock news and headlines – Yahoo Finance - Yahoo Finance Singapore
Nuvation Bio stock rises on Ibtrozi label update (NUVB:NYSE) - Seeking Alpha
Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer - PR Newswire
Nuvation Bio Inc. (NYSE:NUVB) Wins FDA OK To Add ~50-Month DOR To IBTROZI Label - TradingView
Nuvation Bio (NUVB) Reports IBTROZI Efficacy Across ROS1 Lung Cancer Subgroups - Yahoo Finance
Nuvation Bio Announces New Analyses Reinforcing the Durable, Consistent Efficacy of IBTROZI® (taletrectinib) Across Key Patient Subgroups in Advanced ROS1+ NSCLC at 2026 World Conference on Lung Cancer - PR Newswire
Nuvation Bio (NUVB) Stock Looks Stretched Despite Its 354% Three Year Run - webull.com
NUVB: IBTROZI dominates ROS1 with best-in-class efficacy, while safusidenib advances across glioma subtypes - TradingView
Nuvation Bio at 12th Annual Cantor Fitzgerald Global Healthcare Conference: pipeline gains - Investing.com
NUVB: IBTROZI’s superior efficacy and safety drive rapid market share gains, with a strong pipeline advancing - TradingView
Nuvation Bio at 12th Annual Cantor Fitzgerald Global Healthcare Conference: pipeline gains - Investing.com Canada
Nuvation Bio at citigroup biopharma summit: growth rests on three pillars - Investing.com Canada
Nuvation Bio at citigroup biopharma summit: growth rests on three pillars - Investing.com UK
NUVB: IBTROZI and safusidenib drive growth with best-in-class efficacy and expanding global opportunities - TradingView
NUVB: IBTROZI and safusidenib drive strong growth, with major clinical and commercial milestones ahead - TradingView
Jim Cramer sends strong 5-word message on surging biotech stock - Yahoo Finance
Jim Cramer sends strong 5-word message on surging biotech stock - thestreet.com
Jim Cramer: This Health Care Stock Is Pure Spec, The Only Neocloud I Like Is... - Benzinga
Cramer's lightning round: Nuvation Bio 'is a pure spec' - CNBC
Does Nuvation Bio (NUVB) Have the Potential to Rally 91.92% as Wall Street Analysts Expect? - Yahoo Finance
Does Nuvation Bio (NUVB) Have the Potential to Rally 91.92% as Wall Street Analysts Expect? - Zacks Investment Research
Nuvation Bio to Participate in Upcoming Investor Conferences - Investing News Network
Nuvation Bio to Participate in Upcoming Investor Conferences - PR Newswire
Nuvation Bio (NUVB) Upgraded to Buy: Here's Why - Yahoo Finance
Nuvation Bio downgraded to Hold after 200% rall... - Pluang
NUVB|Nuvation Bio Inc|Price:7.100|Chg%:+0.340 - TradingKey
Nuvation Bio | 4: Statement of changes in beneficial ownership of securities-Officer Hattersley Gary - Moomoo
Nuvation Bio (NUVB) CSO sells 100K shares at $7.09 - Stock Titan
Why is Nuvation Bio stock rallying today? By Investing.com - Investing.com Canada
Why is Nuvation Bio stock rallying today? By Investing.com - Investing.com UK
Nuvation Bio stock rises after Cantor starts at Overweight - Investing.com
Nuvation Bio rises as Cantor initiates at overweight - Seeking Alpha
Cantor Fitzgerald initiates Nuvation Bio stock with overweight rating - Investing.com
Cantor Fitzgerald initiates Nuvation Bio stock with overweight rating By Investing.com - Investing.com Canada
Cantor Fitzgerald initiates Nuvation Bio stock with overweight rating By Investing.com - Investing.com India
Cantor Fitzgerald initiates Nuvation Bio stock with overweight rating - Investing.com
JPMorgan sees 100% upside in overlooked cancer drug stock - thestreet.com
FDA grants Nuvation fast-track status for safusidenib in IDH1-mutant glioma - AllSci
2.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):